BTX News and Press, Brooklyn ImmunoTherapeutics Inc. From 06/18/21

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It may not last forever. But, the Reddit stocks phenomenon is here to stay for now. It may go against the philosophy of  investing legends like Warren Buffett . But, as retail investors continue to essentially gambl...

Shares of Brooklyn ImmunoTherapeutics (NYSEMKT: BTX) , no stranger to sharp stock price movements lately, zoomed more than 6% higher on Monday. The catalyst was an acquisition announced that morning by the clincial-stage biotech company. In a joint press release, Brooklyn and No...

Brooklyn ImmunoTherapeutics (BTX) has executed a non-binding letter of intent (“LOI”) to acquire Novellus Therapeutics in a cash and stock deal valued at $125M.Brooklyn shares were up more than 18% during premarket trading.The deal to acquire all of the outst...

NEW YORK, June 14, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics LLC (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, blood disorders, and monogenic ...

BROOKLYN, N.Y., June 09, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics , Inc. (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, blood disorders, and m...

BROOKLYN, N.Y., June 08, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics , Inc. (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, blood disorders, and m...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Among the more interesting clinical-stage biopharmaceutical companies for investors to consider is Brooklyn Immunotherapeutics  (NYSEAMERICAN: BTX ). I won’t claim that everyone needs to own BTX stock, but ...

Koss (KOSS) -14%.C3.ai (AI) -11% on FQ4 earnings release.Stealth BioTherapeutics (MITO) -11%.Express (EXPR) -11% on Q1 earnings releaseFireEye (FEYE) -10% after spins out FireEye Products business to Symphony for $1.2B.Bed Bath & Beyond (BBBY) -10%.PetMed Exp...

Brooklyn ImmunoTherapeutics (BTX) announces that it has established a research and development center in Cambridge, Massachusetts, to pursue its mRNA-based gene editing and cellular therapies.Shares up nearly 5% premarket."Our new R&D facility will provide us with the abili...

BriaCell Therapeutics (BCTX) +102% after update on the overall survival data of advanced breast cancer patients.Constellation Pharmaceuticals (CNST) +67% on merger agreement with MorphoSys.Stealth BioTherapeutics (MITO) +46% on EMA orphan drug status for elamipretide.AC Immune ...